Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. [electronic resource]
- Leukemia research Mar 2002
- 249-54 p. digital
Publication Type: Journal Article
0145-2126
10.1016/s0145-2126(01)00124-2 doi
Adult Aged Aged, 80 and over Antineoplastic Agents--adverse effects Bone Marrow Cells--enzymology Breast Neoplasms--drug therapy Breast Neoplasms, Male--drug therapy Chromosome Aberrations Female Gene Deletion Genotype Glutathione Transferase--genetics Hematologic Neoplasms--etiology Homozygote Humans Karyotyping Leukemia, Myeloid, Acute--chemically induced Leukemia, Radiation-Induced--etiology Lymphocytes--enzymology Male Middle Aged Myelodysplastic Syndromes--chemically induced Radiotherapy--adverse effects Retrospective Studies Risk Factors Translocation, Genetic